The most likely reasons for the higher risk of severe clinical course of COVID-19 in COPD patients could be due to the increased protein levels of the SARS-CoV-2 receptor, namely angiotensin converting enzyme-2 (ACE-2) in the lower respiratory tract. The gene discussed is ACE2; the disease is chronic obstructive pulmonary disease.